CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 2,495 enrolled
Drug / intervention
Not specified
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT01428934
NCT01428934N/ACompleted

Improving Intermediate Risk Management. MARK Study

Fundacio d'Investigacio en Atencio Primaria Jordi Gol i Gurina·observational·Posted Sep 5, 2011·Updated Mar 9, 2018

In Brief

An observational study for Myocardial Infarction and 3 related conditions. Completed, enrolled 2,495 participants across 1 site.

Detailed Summary

Cardiovascular risk functions fail to identify more than 50% of patients who develop cardiovascular disease. This is especially evident in the intermediate-risk patients in which clinical management becomes difficult. The purpose of this study is to analyze if ankle-brachial index (ABI), measures of arterial stiffness, postprandial glucose, glycosylated hemoglobin, self-measured blood pressure and presence of comorbidity are independently associated to incidence of vascular events and whether they can improve the predictive capacity of current risk equations in the intermediate-risk population.

Study Details

Study Typeobservational
Allocation--
Masking--
Primary Purpose--
CountriesSpain

Timeline

N/ACompletedFinished
201220132014201520162017201820192020202120222023202420252026
First PostedSep 5, 2011
Enrollment StartJul 1, 2011
Primary CompletionDec 1, 2013
Study CompletionDec 1, 2016
TodayJul 2, 2026
Enrollment to primary: 2.4 yearsPosted 14.8 years ago